Besch Doug 4
4 · OptimizeRx Corp · Filed Dec 27, 2024
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Besch Doug
Chief Product Officer
Transactions
- Award
Stock Option
2024-12-23+77,742→ 77,742 totalExercise: $4.83From: 2025-12-23Exp: 2027-12-23→ Common Stock (77,742 underlying) - Award
Common Stock
2024-12-23+41,408→ 52,991 total
Footnotes (2)
- [F1]Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on December 23, 2025, which is the first anniversary of the date of grant.
- [F2]The stock option vests in three equal annual installments beginning December 23, 2025, the first anniversary of the grant date.